Kunyang Lei
Papers
2
Total Citations
36
H-Index
2
About
Dr. Kunyang Lei is a pioneering urologic surgeon and researcher whose work centers on advancing robotic-assisted surgical techniques for the treatment of prostate and kidney cancers. His major contributions lie in comparative effectiveness research, where he rigorously evaluates the latest surgical platforms and techniques to improve patient outcomes. His landmark 2021 study, which compared the da Vinci Xi and Si systems for radical prostatectomy (30 citations), provided critical data on perioperative efficacy and cost, directly influencing surgical decision-making in operating rooms worldwide. More recently, Dr. Lei has focused on nephron-sparing surgery, demonstrating through his 2023 work on robotic-assisted tumor enucleation versus partial nephrectomy (6 citations) that more precise, less invasive approaches can be safely applied to complex renal cell carcinoma. By systematically analyzing large patient cohorts, he has helped define best practices for intermediate and high-complexity cases. Dr. Lei’s research is distinguished by its direct clinical applicability, bridging the gap between technological innovation and tangible patient benefit. His work continues to shape the future of minimally invasive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2